These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 239958
21. Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose. Garrett ER, el-Koussi A el-D. J Pharm Sci; 1985 Jan; 74(1):50-6. PubMed ID: 3981418 [Abstract] [Full Text] [Related]
23. Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection. Davidson AF, Emm TA, Pieniaszek HJ. J Pharm Biomed Anal; 1996 Sep; 14(12):1717-25. PubMed ID: 8887719 [Abstract] [Full Text] [Related]
24. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat. Malspeis L, Ludden TM, Bathala MS, Morrison BE, Feller DR, Reuning RH. Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483 [Abstract] [Full Text] [Related]
25. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry. Toennes SW, Kauert GF, Grüsser SM, Jäkel W, Partecke G. J Pharm Biomed Anal; 2004 Apr 01; 35(1):169-76. PubMed ID: 15030891 [Abstract] [Full Text] [Related]
26. Quantitative determination of naltrexone and naltrexone prodrugs by electron-capture gas-liquid chromatography. Burce GL, Bhat HB, Sokoloski T. J Chromatogr; 1977 Jul 21; 137(2):323-32. PubMed ID: 881456 [Abstract] [Full Text] [Related]
27. Kinetics of a naltrexone sustained-release preparation. Chiang CN, Hollister LE, Kishimoto A, Barnett G. Clin Pharmacol Ther; 1984 Nov 21; 36(5):704-8. PubMed ID: 6488691 [Abstract] [Full Text] [Related]
28. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma. Valiveti S, Nalluri BN, Hammell DC, Paudel KS, Stinchcomb AL. J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct 25; 810(2):259-67. PubMed ID: 15380723 [Abstract] [Full Text] [Related]
33. Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol. Porter SJ, Somogyi AA, White JM. Br J Clin Pharmacol; 2000 Nov 25; 50(5):465-71. PubMed ID: 11069441 [Abstract] [Full Text] [Related]
35. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. Verebey K. NIDA Res Monogr; 1981 Nov 25; 28():147-58. PubMed ID: 6791001 [Abstract] [Full Text] [Related]
39. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone. Porter SJ, Somogyi AA, White JM. Addict Biol; 2002 Apr 25; 7(2):219-25. PubMed ID: 12006217 [Abstract] [Full Text] [Related]
40. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys. Reuning RH, Ashcraft SB, Wiley JN, Morrison BE. Drug Metab Dispos; 1989 Apr 25; 17(6):583-9. PubMed ID: 2575491 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]